Literature DB >> 26261620

Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.

Chang-Shan Huang1, Wei Yu1, Hong Cui1, Yun-Jian Wang1, Ling Zhang1, Feng Han1, Tao Huang1.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) play critical roles in hepatocellular carcinoma (HCC) development and progression. Aberrant miR-21 expression has been reported in several cancers. However, the clinical significance of miR-21 in human HCC is still unclear.
METHODS: A total of 112 patients with primary HCC who underwent a curative liver resection were included in this retrospective study. The differentially expressed amount of the miR-21 was validated by quantitative real-time PCR (qRT-PCR). Survival rate was analyzed by log-rank test, and survival curves were plotted according to Kaplan-Meier. Multivariate analysis of the prognostic factors was performed with Cox regression model.
RESULTS: As revealed by qRT-PCR analysis, miR-21 expression was significantly upregulated in HCC tissues when compared with adjacent non-tumor tissues (P<0.05). High miR-21 expression level was observed to be closely correlated with tumor differentiation, TNM stage and vein invasion (P<0.05). Patients who had high miR-21 expression had a shorter overall survival than patients who had low miR-21 expression (P<0.05). Moreover, multivariate analysis of the prognosis factors with a Cox proportional hazards model showed that high miR-21 expression was a significant independent predictor of poor survival in HCC (P<0.05).
CONCLUSION: Our results suggested that increased expression of miR-21 was significantly correlated with tumor progression and could be a novel potential biomarker for HCC prognosis.

Entities:  

Keywords:  hepatocellular carcinoma; miRNA-21; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26261620      PMCID: PMC4525954     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

Review 1.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.

Authors:  Petra Faltejskova; Andrej Besse; Sabina Sevcikova; Lenka Kubiczkova; Marek Svoboda; Jan Smarda; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  Int J Colorectal Dis       Date:  2012-04-03       Impact factor: 2.571

4.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

5.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Authors:  Yannick Ladeiro; Gabrielle Couchy; Charles Balabaud; Paulette Bioulac-Sage; Laura Pelletier; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

6.  High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Authors:  Biyun Qian; Dionyssios Katsaros; Lingeng Lu; Mario Preti; Antonio Durando; Riccardo Arisio; Lina Mu; Herbert Yu
Journal:  Breast Cancer Res Treat       Date:  2008-10-19       Impact factor: 4.872

7.  Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Authors:  O Slaby; M Svoboda; P Fabian; T Smerdova; D Knoflickova; M Bednarikova; R Nenutil; R Vyzula
Journal:  Oncology       Date:  2008-01-15       Impact factor: 2.935

8.  Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.

Authors:  Wenxi Li; Lu Xie; Xianghuo He; Jinjun Li; Kang Tu; Lin Wei; Jun Wu; Yong Guo; Xi Ma; Pingping Zhang; Zhimei Pan; Xin Hu; Yingjun Zhao; Haiyang Xie; Guoping Jiang; Taoyang Chen; Jianneng Wang; Shusen Zheng; Jing Cheng; Dafang Wan; Shengli Yang; Yixue Li; Jianren Gu
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

Review 10.  The role of microRNAs in liver cancer progression.

Authors:  S Huang; X He
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

View more
  28 in total

1.  Cancer exosomes: wanted by many, explored by few, waiting for one.

Authors:  Hien Dang; Xuelian Zhao; Chi-Wing Chow
Journal:  Ann Transl Med       Date:  2017-05

2.  Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.

Authors:  Yusuke Matsuura; Hiroshi Wada; Hidetoshi Eguchi; Kunihito Gotoh; Shogo Kobayashi; Mitsuru Kinoshita; Masahiko Kubo; Koji Hayashi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Takehiro Noda; Koichi Kawamoto; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2018-11-22       Impact factor: 3.199

Review 3.  Adipokines Regulate the Expression of Tumor-Relevant MicroRNAs.

Authors:  Simon Jasinski-Bergner; Heike Kielstein
Journal:  Obes Facts       Date:  2019-04-18       Impact factor: 3.942

4.  Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma.

Authors:  Jing Shen; Qiao Wang; Irina Gurvich; Helen Remotti; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-11-18

Review 5.  Exosomal microRNAs in hepatocellular carcinoma.

Authors:  Chenbin Liu; Han Wu; Yinqi Mao; Wei Chen; Shuying Chen
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

Review 6.  Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Stijn Van Hees; Peter Michielsen; Thomas Vanwolleghem
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

Review 7.  Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.

Authors:  Sijia Shen; Yuxin Lin; Xuye Yuan; Li Shen; Jiajia Chen; Luonan Chen; Lei Qin; Bairong Shen
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

8.  Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.

Authors:  Rui Zhang; Li-Jie Zhang; Mei-Ling Yang; Lan-Shan Huang; Gang Chen; Zhen-Bo Feng
Journal:  Mol Med Rep       Date:  2017-11-27       Impact factor: 2.952

9.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

10.  Identifying FBLN1 (Gene ID: 2192) as a Potential Melanoma Biomarker for Melanoma based on an Analysis of microRNA Expression Profiles in the GEO and TCGA Databases.

Authors:  Xiao-Tian Liu; Tian-Tian Liu; Meng-Yuan Wu; Qing-Xi Chen; Jiang-Xing Zhuang; Qin Wang
Journal:  Genet Test Mol Biomarkers       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.